Abdu Gumaei^1,2,*, Mabrook Al-Rakhami¹, Mohamad Mahmoud Al Rahhal³, Fahad Raddah H. Albogamy³, Eslam Al Maghayreh³, Hussain AlSalman¹

CMC-Computers, Materials & Continua, Vol.66, No.1, pp. 315-329, 2021, DOI:10.32604/cmc.2020.012045

Abstract The fast spread of coronavirus disease (COVID-19) caused by SARSCoV-2 has become a pandemic and a serious threat to the world. As of May 30, 2020, this disease had infected more than 6 million people globally, with hundreds of thousands of deaths. Therefore, there is an urgent need to predict confirmed cases so as to analyze the impact of COVID-19 and practice readiness in healthcare systems. This study uses gradient boosting regression (GBR) to build a trained model to predict the daily total confirmed cases of COVID-19. The GBR method can minimize the loss function of the training process and… More >

Panagiotis G. Asteris^1,*, Maria G. Douvika¹, Chrysoula A. Karamani¹, Athanasia D. Skentou¹, Katerina Chlichlia², Liborio Cavaleri³, Tryfon Daras⁴, Danial J. Armaghani⁵, Theoklis E. Zaoutis⁶

CMES-Computer Modeling in Engineering & Sciences, Vol.125, No.2, pp. 815-828, 2020, DOI:10.32604/cmes.2020.013280

Abstract The modeling and risk assessment of a pandemic phenomenon such as COVID-19 is an important and complicated issue in epidemiology, and such an attempt is of great interest for public health decision-making. To this end, in the present study, based on a recent heuristic algorithm proposed by the authors, the time evolution of COVID-19 is investigated for six different countries/states, namely New York, California, USA, Iran, Sweden and UK. The number of COVID-19-related deaths is used to develop the proposed heuristic model as it is believed that the predicted number of daily deaths in each country/state includes information about the… More >

Jodi L. Feinberg¹, Frank Cecchin^1,2, Arianna Gonzalez¹, Emily Johnson², Dan G. Halpern^1,*

Congenital Heart Disease, Vol.15, No.3, pp. 141-146, 2020, DOI:10.32604/CHD.2020.012039

Abstract Adults with congenital heart disease (ACHD) are likely at increased risk for complications of COVID-19. ACHD centers should prepare to deliver routine cardiac care and support for patients with COVID-19 safely at home, as the number of COVID-19 infections worldwide continues to increase. This brief report aims to share the strategies we have used in our ACHD program to manage and treat our patients during this global health crisis at one of the initial epicenters of the pandemic in New York City, and offer suggestions for preparation for ACHD clinicians. More >

Rashid Iqbal Khan^1,*, Mazhar Abbas¹, Khurram Goraya², Muhammad Zafar-ul-Hye³, Subhan Danish³

Phyton-International Journal of Experimental Botany, Vol.89, No.3, pp. 438-452, 2020, DOI:10.32604/phyton.2020.010972

Abstract COVID-19 caused by SARS-CoV-2 is declared global pandemic. The virus owing high resemblance with SARS-CoV and MERS-CoV has been placed in family of beta-coronavirus. However, transmission and infectivity rate of COVID-19 is quite higher as compared to other members of family. Effective management strategy with potential drug availability will break the virus transmission chain subsequently reduce the pressure on the healthcare system. Extensive research trials are underway to develop novel efficient therapeutics against SARS-CoV-2. In this review, we have discussed the origin and family of coronavirus, structure, genome and pathogenesis of virus SARS-CoV-2 inside human host cell; comparison among SARS,… More >

WENJUAN LI^*, GE SONG

BIOCELL, Vol.44, No.2, pp. 127-135, 2020, DOI:10.32604/biocell.2020.010018

Abstract From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this review for a brief summary. More >